Literature DB >> 20647824

How long is the right interval for assessing antiretroviral pharmacy refill adherence?

Trisha L Acri, Robert M Grossberg, Robert Gross.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20647824      PMCID： PMC2946233          DOI： 10.1097/QAI.0b013e3181ed1626

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN： 1525-4135            Impact factor:   3.731


× No keyword cloud information.
  5 in total

1.  A time-to-prescription-refill measure of antiretroviral adherence predicted changes in viral load in HIV.

Authors:  Robert Grossberg; Yawei Zhang; Robert Gross
Journal:  J Clin Epidemiol       Date:  2004-10       Impact factor: 6.437

2.  The elusive gold standard. Future perspectives for HIV adherence assessment and intervention.

Authors:  Margaret A Chesney
Journal:  J Acquir Immune Defic Syndr       Date:  2006-12-01       Impact factor: 3.731

3.  A simple, dynamic measure of antiretroviral therapy adherence predicts failure to maintain HIV-1 suppression.

Authors:  Robert Gross; Benita Yip; Vincent Lo Re; Evan Wood; Christopher S Alexander; P Richard Harrigan; David R Bangsberg; Julio S G Montaner; Robert S Hogg
Journal:  J Infect Dis       Date:  2006-09-12       Impact factor: 5.226

4.  Lack of association between retrospectively collected pharmacy refill data and electronic drug monitoring of antiretroviral adherence.

Authors:  Trisha Acri; Thomas R TenHave; Jennifer C Chapman; Hillary R Bogner; Robert Gross
Journal:  AIDS Behav       Date:  2008-12-16

5.  How long is the window of opportunity between adherence failure and virologic failure on efavirenz-based HAART?

Authors:  Robert Gross; Warren B Bilker; Hao Wang; Jennifer Chapman
Journal:  HIV Clin Trials       Date:  2008 May-Jun
  5 in total
  4 in total

1.  Role of the Pharmacist in Caring for Patients with HIV/AIDS: Clinical Practice Guidelines.

Authors:  Alice Tseng; Michelle Foisy; Christine A Hughes; Deborah Kelly; Shanna Chan; Natalie Dayneka; Pierre Giguère; Niamh Higgins; Cara Hills-Nieminen; Jeff Kapler; Charles J L la Porte; Pam Nickel; Laura Park-Wyllie; Carlo Quaia; Linda Robinson; Nancy Sheehan; Shannon Stone; Linda Sulz; Deborah Yoong
Journal:  Can J Hosp Pharm       Date:  2012-03

2.  Single tablet HIV regimens facilitate virologic suppression and retention in care among treatment naïve patients.

Authors:  Vagish Hemmige; Charlene A Flash; Josephinel Carter; Thomas P Giordano; Teddy Zerai
Journal:  AIDS Care       Date:  2018-02-25

3.  Short term adherence tool predicts failure on second line protease inhibitor-based antiretroviral therapy: an observational cohort study.

Authors:  Richard Court; Rory Leisegang; Annemie Stewart; Henry Sunpath; Richard Murphy; Philip Winternheimer; Mashuda Ally; Gary Maartens
Journal:  BMC Infect Dis       Date:  2014-12-04       Impact factor: 3.090

4.  Pharmacy refill data can be used to predict virologic failure for patients on antiretroviral therapy in Brazil.

Authors:  David Martin; Paula M Luz; Jordan E Lake; Jesse L Clark; Dayse P Campos; Valdilea G Veloso; Ronaldo I Moreira; Sandra W Cardoso; Jeffrey D Klausner; Beatriz Grinsztejn
Journal:  J Int AIDS Soc       Date:  2017-06-05       Impact factor: 5.396
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.